| Subjects | Location | Acupoint | Intervention | Time of intervention | Signal pathway | Main results | Author, reference |
| Male SD rats, rotenone injection | substantia nigra | GV16, LR3 | EA, 1mA, 2Hz | 20min, QD for 14 days | inactivation of p38-MAPK pathway | elevation of tyrosine hydroxylase-positive neuron depression of phosphorylated p38-MAPK, COX-2 decrease neuroinflammation | Wang SJ, et al. 2013[158] |
| Male SD rats, rotenone injection | substantia nigra | GV16, LR3 | EA, 2mA, 2Hz | 20min, QD for 14 days | inactivation of ERK 1/2 pathway | elevation of tyrosine hydroxylase protein depression of p-ERK 1/2, TNF-α, IL-1β decrease neuroinflammation | Wang SJ, et al. 2014[159] |
| Male C57BL/6 mice, MPTP injection | substantia nigra, striatum | GB34 | MA, 2Hz for 15sec | QD for 7 days | activation of PI3K/Akt pathway | elevation of pAkt prevents MPTP-induced dopaminergic neuron degeneration | Kim SN, et al. 2011[160] |
| Male C57BL/6 mice, MPTP injection | substantia nigra pars compacta, striatum | GB34 | MA, 2Hz for 15sec | QD for 12 days | activation of PI3K/Akt pathway | elevation of dopamine depression of dopamine- and cAMP-regulated phosphoprotein of 32 kDa, Fos increase dopamine turnover rate | Kim SN, et al. 2011[161] |
| Male, C57BL6 mice (MPTP intraperitoneal injection) and SD rats (Sigma-Aldrich injection into substantia nigra) | substantia nigra | GB34, LR3 | EA, 1mA, 50Hz | QD for 5(mice)/7(rats) days | activation of Akt pathway | elevation of BDNF, Bcl-2, tyrosine hydroxylase regulation of cell cycle | Lin JG, et al. 2017[162] |
| Imprinting control region mouse pups, systemic 6- hydroxydopamine injection | hippocampus | KI3 | EA, 1mA, 2Hz | 15min, QD, 5 days/wk for 6wks | inactivation of pPKA/pPKC/CaMKIIα signaling pathways | depression of pNR1, pNR2B, pPKA, pPKC, pCaMKIIα, pERK, pCREB reduce neuronal excitotoxicity | Lu KW, et al. 2017[163] |
| Male C57BL/6 mice, MPTP injection | substantia nigra par compacta | GB34 | MA, 2Hz for 15sec every 5min | 10min, QD for 7 days | m-TOR independent pathway | depression of α-synuclein induces autophagic clearance of α-syn, dopaminergic neurons protection | Tian T, et al. 2016[164] |
| Male C57BL/6 mice, MPTP injection | substantia nigra, striatum | GB34, GB39 | EA, 1mA, 100Hz | 20min, QD for 12 days | regulation of glyoxalase system | elevation of tyrosine hydroxylase-positive neurons, cytochrome c oxidase subunit Vb depression of cytosolic malate dehydrogenase, munc18-1, hydroxyacylglutathione hydrolase anti-oxidative effect | Kim ST, et al. 2010[165] |
| Male C57BL/6 mice, MPTP injection | midbrain, striatum | ST36, SP6 | EA, 1-1.4mA, 100Hz | 30min, QD for 12 days, except day 7 | activation of Nrf2-ARE pathway | elevation of tyrosine hydroxylase, ARE-driven reporter gene, NQO1, HO-1 depression of ionized calcium-binding adaptor molecule 1, TNF-α, IL-6, IL-1β anti-oxidative effect | Lv E, et al. 2015[166] |
| GFAP-tTA/tetO-α-syn double transgenic mice | midbrain, striatum | ST36, SP6 | EA, 1-1.2mA, 100Hz | 30min, QD for 28 days | activation of Nrf2-ARE pathway | elevation of Nrf2, HO-1, glutamate-cysteine ligase modifier subunits depression of α-syn decrease astrogliosis and neuroinflammation | Deng J, et al. 2015[167] |
| Male C57BL/6 mice, MPTP injection | striatum, substantia nigra | GB34 | MA, 2Hz, 15sec | QD for 12 days | activation of p53 signaling pathways | elevation of p53 dopaminergic neuron protection | Park JY, et al. 2015[168] |
|
|